These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11174841)

  • 1. Mitotane-induced febrile pancytopenia: a first case report in paraneoplastic Cushing's syndrome.
    Andrès E; Vinzio S; Goichot B; Schlienger JL
    Eur J Endocrinol; 2001 Jan; 144(1):81. PubMed ID: 11174841
    [No Abstract]   [Full Text] [Related]  

  • 2. 18 years mitotane therapy for intractable Cushing's disease.
    Kawai S; Ichikawa Y; Kaburaki J; Yoshida T
    Lancet; 1999 Sep; 354(9182):951. PubMed ID: 10489980
    [No Abstract]   [Full Text] [Related]  

  • 3. [Idiopathic intracranial hypertension during treatment of Cushing's disease with mitotane].
    Marechaud R; Boissonnot M; Holderer-Fieuzal S; Gouet D; Boissonnot L
    Presse Med; 1987 Dec; 16(42):2131. PubMed ID: 2963295
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitotane. Spironolactone antagonism in Cushing's syndrome.
    Wortsman J; Soler NG
    JAMA; 1977 Dec; 238(23):2527. PubMed ID: 578890
    [No Abstract]   [Full Text] [Related]  

  • 5. Cushing's disease.
    Trainer PJ; Besser M
    Lancet; 2000 Jan; 355(9197):68. PubMed ID: 10615912
    [No Abstract]   [Full Text] [Related]  

  • 6. [Remission of recurrent Cushing's disease with an analog of somatostatin].
    Lorcy Y; Derennes V; Delambre C; Leguerrier A; Legrand S; Allannic H
    Presse Med; 1988 Jun; 17(23):1217. PubMed ID: 2899888
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neurotoxicity of mitotane therapy of adrenocortical carcinoma (5 cases) and Cushing's syndrome (7 cases)].
    du Rostu H; Krempf M; Mussini JM; Murat A; Guillon J; Charbonnel B
    Presse Med; 1987 May; 16(19):951-4. PubMed ID: 2954144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma.
    Baudry C; Paepegaey AC; Groussin L
    N Engl J Med; 2013 Aug; 369(6):584-6. PubMed ID: 23924025
    [No Abstract]   [Full Text] [Related]  

  • 9. Cushing's syndrome associated with a bronchial adenoma. Possible periodic hormonogenesis.
    Shapiro MS; Gutman A; Bruderman I; Myers B; Griffel WB
    Isr J Med Sci; 1975 Sep; 11(9):919-24. PubMed ID: 1184365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [12 years of medical treatment of Cushing's disease. Long-term use of Op, DDD in 46 cases].
    Bricaire H; Luton JP
    Nouv Presse Med; 1976 Feb; 5(6):325-9. PubMed ID: 1264700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The long-term therapy of hypothalamic-hypophyseal Cushing's syndrome with mitotane (o,p'-DDD)].
    Knappe G; Gerl H; Ventz M; Rohde W
    Dtsch Med Wochenschr; 1997 Jul; 122(28-29):882-6. PubMed ID: 9264918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Cushing's syndrome during effective chemotherapy for small cell lung cancer.
    Suyama K; Naito Y; Yoh K; Niho S; Goto K; Ohmatsu H; Nishiwaki Y; Ohe Y
    Intern Med; 2011; 50(4):335-8. PubMed ID: 21325767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal and pituitary effects of mitotane in Cushing's syndrome.
    Kasperlik-Załuska A; Jeske W; Migdalska B
    Endokrynol Pol; 1986; 37(1):17-21. PubMed ID: 3015579
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with Lysodren treatment of Cushing's syndrome in dogs].
    Opitz M; Lettow E; Loppnow H; Grevel V
    Tierarztl Prax; 1983; 11(4):507-20. PubMed ID: 6658774
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptomatic Cushing's syndrome and hyperandrogenemia in a steroid cell ovarian neoplasm: a case report.
    Sedhom R; Hu S; Ohri A; Infantino D; Lubitz S
    J Med Case Rep; 2016 Oct; 10(1):278. PubMed ID: 27729065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraendocrine syndromes.
    Pierce ST
    Curr Opin Oncol; 1993 Jul; 5(4):639-45. PubMed ID: 8364080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mitotane on Alternaria alternata infection in Cushing's syndrome.
    Kasperlik-Zaluska AA; Bieluńska S
    Lancet; 1991 Jan; 337(8732):53-4. PubMed ID: 1670675
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of Cushing's disease treated with o,p'-DDD].
    Kaneko K; Saito T; Fujioka T; Sugita Y; Takai K
    Horumon To Rinsho; 1982 Oct; 30(10):1071-6. PubMed ID: 7165981
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of cholesterol oxidase in a patient with Cushing's syndrome.
    Davey DD; Alber DB; Ryder KW; Jones JM; Hostetler ML; Moorehead WR; Oei TO
    Clin Chem; 1984 Apr; 30(4):572-4. PubMed ID: 6584245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.